Cargando…

N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer

BACKGROUND: Single-nucleotide polymorphisms (SNPs) in N6-methyladenosine (m6A) related genetic locus play significant roles in tumorigenesis and development. The expression level of many oncogenes and tumour suppressor genes changed because of m6A-associated SNPs. In addition, the relationship betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Jiancheng, Song, Qiang, Bai, Kexin, Han, Jie, Yu, Hao, Li, Kai, Zhuang, Juntao, Yang, Xiao, Yang, Haiwei, Lu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535860/
https://www.ncbi.nlm.nih.gov/pubmed/36199110
http://dx.doi.org/10.1186/s12935-022-02701-z
_version_ 1784802863770238976
author Lv, Jiancheng
Song, Qiang
Bai, Kexin
Han, Jie
Yu, Hao
Li, Kai
Zhuang, Juntao
Yang, Xiao
Yang, Haiwei
Lu, Qiang
author_facet Lv, Jiancheng
Song, Qiang
Bai, Kexin
Han, Jie
Yu, Hao
Li, Kai
Zhuang, Juntao
Yang, Xiao
Yang, Haiwei
Lu, Qiang
author_sort Lv, Jiancheng
collection PubMed
description BACKGROUND: Single-nucleotide polymorphisms (SNPs) in N6-methyladenosine (m6A) related genetic locus play significant roles in tumorigenesis and development. The expression level of many oncogenes and tumour suppressor genes changed because of m6A-associated SNPs. In addition, the relationship between m6A-SNP and bladder cancer (BCa) has not been well studied. METHODS: We screened m6A-SNPs in BCa by combining m6A-SNPs data and GWAS-SNPs data. Expression quantitative trait loci (eQTL) and differential expression gene (DEGs) analyses were performed. In ring finger protein, transmembrane 2 (RNFT2), rs3088107 (C  > G) was found to have significant eQTL signals and make RNFT2 gene differentially-regulated mostly in BCa. We validated the expression level of RNFT2 in 32 pairs of BCa tissues and eight BCa cell lines by quantitative real-time PCR (qRT-PCR). Functional assays were performed to investigate the role of rs3088107 and RNFT2 in BCa in vitro. RESULTS: We identified 673 m6A-SNPs, which were associated with BCa. Of these m6A-SNPs, 221 showed eQTL signals, amongst which, rs3088107 in RNFT2 showed significant eQTL signals. Results of bioinformatic analyses showed that 11 genes with m6A-SNPs had a differential expression level in BCa. RNFT2 was predicted to be significantly up-regulated in BCa. The qRT-PCR results validated that RNFT2 was highly expressed in our own BCa tissues and cell lines. High expression of RNFT2 also indicated a worse overall survival. We also revealed that rs3088107 (C  > G) could inhibit the expression and m6A modification of RNFT2 by qRT-PCR, western-blot and m6A-RIP assays. Moreover, the results of functional assays indicated that RNFT2 promoted BCa cell proliferation and migration. CONCLUSION: This research found that m6A-SNPs were associated with oncogene RNFT2 in BCa. Furthermore, m6A-SNPs showed great application potential as a new BCa diagnostic biomarker and prognostic indicator. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02701-z.
format Online
Article
Text
id pubmed-9535860
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95358602022-10-07 N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer Lv, Jiancheng Song, Qiang Bai, Kexin Han, Jie Yu, Hao Li, Kai Zhuang, Juntao Yang, Xiao Yang, Haiwei Lu, Qiang Cancer Cell Int Research BACKGROUND: Single-nucleotide polymorphisms (SNPs) in N6-methyladenosine (m6A) related genetic locus play significant roles in tumorigenesis and development. The expression level of many oncogenes and tumour suppressor genes changed because of m6A-associated SNPs. In addition, the relationship between m6A-SNP and bladder cancer (BCa) has not been well studied. METHODS: We screened m6A-SNPs in BCa by combining m6A-SNPs data and GWAS-SNPs data. Expression quantitative trait loci (eQTL) and differential expression gene (DEGs) analyses were performed. In ring finger protein, transmembrane 2 (RNFT2), rs3088107 (C  > G) was found to have significant eQTL signals and make RNFT2 gene differentially-regulated mostly in BCa. We validated the expression level of RNFT2 in 32 pairs of BCa tissues and eight BCa cell lines by quantitative real-time PCR (qRT-PCR). Functional assays were performed to investigate the role of rs3088107 and RNFT2 in BCa in vitro. RESULTS: We identified 673 m6A-SNPs, which were associated with BCa. Of these m6A-SNPs, 221 showed eQTL signals, amongst which, rs3088107 in RNFT2 showed significant eQTL signals. Results of bioinformatic analyses showed that 11 genes with m6A-SNPs had a differential expression level in BCa. RNFT2 was predicted to be significantly up-regulated in BCa. The qRT-PCR results validated that RNFT2 was highly expressed in our own BCa tissues and cell lines. High expression of RNFT2 also indicated a worse overall survival. We also revealed that rs3088107 (C  > G) could inhibit the expression and m6A modification of RNFT2 by qRT-PCR, western-blot and m6A-RIP assays. Moreover, the results of functional assays indicated that RNFT2 promoted BCa cell proliferation and migration. CONCLUSION: This research found that m6A-SNPs were associated with oncogene RNFT2 in BCa. Furthermore, m6A-SNPs showed great application potential as a new BCa diagnostic biomarker and prognostic indicator. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-022-02701-z. BioMed Central 2022-10-05 /pmc/articles/PMC9535860/ /pubmed/36199110 http://dx.doi.org/10.1186/s12935-022-02701-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lv, Jiancheng
Song, Qiang
Bai, Kexin
Han, Jie
Yu, Hao
Li, Kai
Zhuang, Juntao
Yang, Xiao
Yang, Haiwei
Lu, Qiang
N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
title N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
title_full N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
title_fullStr N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
title_full_unstemmed N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
title_short N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer
title_sort n6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene rnft2 in bladder cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535860/
https://www.ncbi.nlm.nih.gov/pubmed/36199110
http://dx.doi.org/10.1186/s12935-022-02701-z
work_keys_str_mv AT lvjiancheng n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT songqiang n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT baikexin n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT hanjie n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT yuhao n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT likai n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT zhuangjuntao n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT yangxiao n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT yanghaiwei n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer
AT luqiang n6methyladenosinerelatedsinglenucleotidepolymorphismanalysesidentifyoncogenernft2inbladdercancer